About MTIP
MTIP is a venture capital firm founded in 2014. It is primarily based out of Basel, Switzerland. As of Dec 2024, MTIP has invested in 18 companies. It primarily invests in Series C round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Series B round of Nitinote Surgical Overall, MTIP portfolio has seen 5 acquisitions including key companies like Koa Health, Trialbee and Cynerio. A lot of funds co-invest with MTIP, with names like Elron Ventures sharing a substantial percentage of its portfolio. MTIP has team of 9 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 2 more
Portfolio Acquisitions
MTIP's List of Top Investments
MTIP has a portfolio of 18 companies. Their most notable investments are in Oviva and LynxCare.Their portfolio spans across United States, United Kingdom, Germany and 6 more locations. They have invested in HealthTech, Enterprise Applications, Life Sciences and 3 other sectors, across stages such as Series B, Series A and 2 more. Here is the list of top investments by MTIP:1. Oviva
Provider of an online nutritional consultation platform for patients. It offers personalised dietary advice combined with unique digital tools. The dietitian offers personalized guidance based on their needs and answers user's questions in regard to dietary management solutions. They also help users to track their daily activities for better health outcomes. The app gives daily motivation and tips to users to reach their goals.
Key facts about Oviva
- Founded Year: 2014
- Location: London (United Kingdom)
- Stage: Series D
- Total Funding till date: $118M
- Employee Count: 944 as on Jun 30, 2026
- Investors: F-Prime Capital, Temasek and 19 Others
- Latest Funding Round: Series D, Jan 22, 2026, $*****
- Highlight: Editors' Pick
2. Tyto Care
Tyto care is a mobile and web-based health platform and device, allowing anyone to perform a self-physical examination, remote diagnosis, and consultation with a physician. Tyto Care's solution combines a handheld device and online communication platform designed to allow seamless interaction between patients and clinicians over the web. The device can be swiped across the forehead to receive temperature readings, used to record heart rate and rhythm and also lung sounds if a stethoscope attachment is used, used to capture digital images of the ear canal, throat or skin to enable diagnosing infections.
Key facts about Tyto Care
- Founded Year: 2011
- Location: Netanya (Israel)
- Stage: Series D
- Total Funding till date: $224M
- Employee Count: 221 as on Mar 31, 2026
- Investors: Qualcomm Ventures, Qumra Capital and 24 Others
- Latest Funding Round: Series D, Jul 15, 2026, $*****
- Highlight: Editors' Pick

3. Koa Health
Provider of digitally-enabled mental health therapies and platform solutions. It offers clinically validated treatments for anxiety, PTSD, and social anxiety in children, teens, and adults. The solutions are designed for use by healthcare providers and families, facilitating collaboration towards recovery. A unified platform, provides access to support across the mental health continuum, encompassing lifestyle, prevention, and therapy. It also offers data and analytics to support population level insights. The approach prioritizes prevention and utilizes evidence based care. Healthcare providers use the platform to provide patients with mobile assisted tools for teleconsultation, mental health activities, stress management, and more. Mobile first treatments and progress-tracking tools are built by the company for the payers to monitor clients health and condition.
Key facts about Koa Health
- Founded Year: 2016
- Location: London (United Kingdom)
- Annual Revenue: £0 - £1M as on Dec 31, 2023
- Stage: Acquired
- Total Funding till date: $36M
- Employee Count: 42 as on Jun 30, 2026
- Investors: Wellington Partners Venture Capital, AA Sons and 9 Others
- Latest Funding Round: Series A, Oct 2020, $*****
- Highlight: Acquired
NitiNotes is focussed on developing non-surgical bariatric solutions for obesity issues. The company has received funding from Accelmed, an investment firm focused on value creation for medical device companies and technologies. As of Apr 2017, the company is operating from Peregrine's incubator and hasn't disclosed its product information and development details.
Key facts about Nitinote Surgical
- Founded Year: 2014
- Location: Ramat Gan (Israel)
- Stage: Series B
- Total Funding till date: $26.1M
- Employee Count: 35 as on Jun 30, 2026
- Investors: Accelmed, Arkin Holdings and 6 Others
- Latest Funding Round: Series B, Dec 23, 2024, $*****
- Highlight: Editors' Pick
Provider of a dialysis system offering multiple kidney therapy modalities. The company offers Dialysis System to provide multiple hemodialysis modalities on a single, convenient platform without the need for traditional bags. This versatility allows healthcare providers to utilize the same system for different clinical requirements.
Key facts about Quanta Dialysis Technologies
- Founded Year: 2008
- Location: Warwick (United Kingdom)
- Annual Revenue: £0 - £1M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $433M
- Employee Count: 142 as on Jun 30, 2026
- Investors: Stage Capital, Monashee Investment Management and 30 Others
- Latest Funding Round: Series E, Nov 18, 2024, $*****
- Highlight: Editors' Pick
MTIP's Year-on-Year Investment Trends
MTIP has invested in 19 companies over the last 11 years, with an average of 2 new investments annually in the last 10 years. Its most recent first time investment was in Hexarad and most recent follow-on round was in Nitinote Surgical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 2 | 2 | 4 |
2023 | 0 | 1 | 1 |
2022 | 2 | 0 | 2 |
2021 | 4 | 1 | 5 |
2020 | 3 | 1 | 4 |
2019 | 1 | 0 | 1 |
2018 | 3 | 0 | 3 |
2017 | 2 | 0 | 2 |
MTIP's Investments by Stage
MTIP has made 7 investments in Series B stage with an average round size of $17.6M, 6 investments in Series A stage with an average round size of $15.8M, 4 investments in Series C stage with an average round size of $28.8M and 1 investment in Seed stage.Stage of entry | No. of Investments |
|---|---|
Series B | 7 |
Series A | 6 |
Series C | 4 |
Seed | 1 |
Note: We have considered here, only first round of investments
MTIP's Investments by Sector
MTIP has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, Vertical SaaS and High Tech. Notably, it has invested in 17 Tech companies, 15 Enterprise (B2B) companies, 11 Software companies and at least 4 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 12 |
Enterprise Applications | 9 |
Life Sciences | 7 |
Vertical SaaS | 4 |
High Tech | 3 |
Others | 7 |
Note: We have considered here, only first round of investments
MTIP's Investments by Geography
MTIP has made most investments in United States (5), followed by United Kingdom where it has made 5 investments.Country | No. of Investments |
|---|---|
United Kingdom | 5 |
United States | 5 |
Germany | 2 |
Israel | 2 |
China | 1 |
Others | 4 |
Note: We have considered here, only first round of investments
MTIP's recent investments
MTIP has not made any investment in 2026 so far.Here are the most recent investments by MTIP:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 23, 2024 | Israel | Series B | 1864 | [+1] | |
Aug 15, 2024 | United States | Series C | 9924 | [+13] | |
Jun 20, 2024 | United Kingdom | Series B | 5576 | ||
Feb 14, 2024 | United States | Series C | 1479 | [+10] | |
Sep 28, 2023 | Israel | Series B | 6800 | - |
Acquired companies in MTIP's Portfolio
5 companies from MTIP's portfolio have been acquired. The most recent acquisition was Koa Health in Jun 2026 by PsychPlus for $*****.Here are MTIP's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 23, 2026 | Oct 2020 | Series A | 7542 | |
Jan 07, 2026 | Apr 28, 2020 | Series B | 3639 | |
Jul 26, 2025 | May 18, 2021 | Series B | 4788 | |
Aug 08, 2024 | Dec 04, 2018 | Series C | 5937 | |
Jan 22, 2020 | Jul 11, 2017 | Series B | 4907 |
Team profile of MTIP
MTIP has a team of 9 members including 2 Partners and 4 Principals located in Switzerland and United Kingdom. MTIP's team does not sit on the board of any company as of now.Here is a list of all team members in MTIP:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Basel | - | - | |
Partner | Basel | - | ||
Principal | Zurich | - | ||
Principal | Basel | - | ||
Principal | London | - | ||
Principal | Switzerland | - | - |
Co-investors of MTIP
Over the past 11 years, 148 investors have co-invested in MTIP's portfolio companies. This includes funds and angels.
- Invested before MTIP: b2venture, IPF Partners and 75 others have invested in rounds before MTIP. There are 2 companies where b2venture has invested before MTIP and 2 companies where IPF Partners has invested before MTIP.
- Top Co-investors of MTIP: 30 investors entered a company along with MTIP. These include investors like Elron Ventures (2 companies).
- Invested after MTIP: A total of 41 investors have invested in MTIP's portfolio after their investments. Top Investors include Temasek (1 company), Sofina (1 company) and Kinnevik (1 company).
Recent News related to MTIP
•
Coulter Partners Recruits Chief Development Officer for CellCentricHunt Scanlon•Oct 02, 2024•Coulter Partners, cellcentric, MTIP, Nitinote Surgical
•
Caresyntax brings in $180M for its vendor-neutral precision platformThe Robot Report•Aug 17, 2024•Caresyntax, Symbiotic Capital, MTIP, Bioniq and 18 others
•
Caresyntax secures $180M to build AI-powered ‘Android of robotic surgery’Techio•Aug 15, 2024•Caresyntax, Symbiotic Capital, Optum Ventures, BlackRock and 16 others
•
surgical.ai Backs Caresyntax in $180M Series C Extension to Accelerate Adoption of AI-enabled Surgeryintelligence360•Aug 15, 2024•Surgical, Caresyntax, Symbiotic Capital, MTIP and 13 others
•
Hexarad handed £11m growth investmentBusinessCloud•Aug 15, 2024•Hexarad, MTIP, Foresight Group, Sentient Labs
•
Apricity raises a €17m Series B round led by MTIPBrightCap Ventures•Sep 05, 2022•WOOM, Apricity, BrightCap Ventures, MTIP and 3 others
•
Belgian AI-powered clinical data platform LynxCare has raised €20 millionexplode.africa•Jun 23, 2022•LynxCare, MTIP, Elaia, HERAN Partners and 2 others
•
•
Oviva raises $80m in Series C fundingAlbion Capital Group•Sep 01, 2021•Oviva, Sofina, Temasek, Albion Capital Group and 5 others
•
Potsdam diabetes app receives 68 million eurosBusiness Insider Deutschland•Aug 31, 2021•Oviva, Earlybird, Eight Roads Ventures, MTIP and 5 others

